Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.

Diagnosis and Testing

What are the most common presenting signs and symptoms of COVID-19? What are the more serious signs of a life-threatening situation? What are the indications for ICU admission that non-ICU clinicians must be aware of?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on August 12, 2020.

Clinical presentations, Coronavirus, COVID-19, Diagnosis and Testing

What is the approach in the emergency department for patients who arrive with potential COVID-19 symptoms? What triage, diagnostic, and treatment practices are in place?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on October 14, 2020.

Coronavirus, COVID-19, Diagnosis and Testing, Therapies, Triage

What is the difference between pulse oximetry and arterial oxygen tension

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on September 9, 2020.

Coronavirus, COVID-19, Diagnosis and Testing, Hemodynamic Support

Letter to the Editor: Prevalence and Clinical Correlates of Echo-Estimated Right and Left Heart Filling Pressures in Hospitalized Patients With Coronavirus Disease 2019

From Critical Care Explorations In this Letter to the Editor, the authors discuss their study in which they hypothesized that a significant proportion of coronavirus disease 2019 patients has evidence of pulmonary hypertension associated with elevated left heart filling pressure on transthoracic echocardiography.

Cardiovascular, Coronavirus, COVID-19, Diagnosis and Testing

Point-of-Care Lung Ultrasound for Detecting Severe Presentations of Coronavirus Disease 2019 in the Emergency Department: A Retrospective Analysis

From Critical Care Explorations. In this study, lung ultrasound diagnosed severe presentations of coronavirus disease 2019 with similar sensitivity to chest radiograph, CT, and reverse transcriptase-polymerase chain reaction (on first testing) and improved specificity compared to chest radiograph.
 

Coronavirus, COVID-19, Diagnosis and Testing

Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients

From Critical Care Explorations. In this study, the authors found that targeted proteomics with feature classification easily distinguished both healthy control subjects and coronavirus disease 2019 tested negative ICU patients from coronavirus disease 2019 tested positive ICU patients. Multiple proteins were identified that accurately predicted coronavirus disease 2019 tested positive patient mortality.

Coronavirus, COVID-19, Diagnosis and Testing

Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation

From Critical Care Explorations. The authors found that thrombosis profiling identified endothelial activation and glycocalyx degradation in coronavirus disease 2019 positive patients and believe that the data from this study suggest that medications to protect and/or restore the endothelial glycocalyx, as well as platelet inhibitors, should be considered for further study.

Coronavirus, COVID-19, Diagnosis and Testing, Therapies

Thromboelastography to Detect Hypercoagulability and Reduced Fibrinolysis in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients

From Critical Care Explorations. In this study, the authors investigated thromboelastography in patients with coronavirus disease 2019-associated acute respiratory distress syndrome with the goal of characterizing suspected coagulopathy and impaired fibrinolysis.
 

Coronavirus, COVID-19, Diagnosis and Testing

Probative Value of the D-Dimer Assay for Diagnosis of Deep Venous Thrombosis in the Coronavirus Disease 2019 Syndrome

From Critical Care Medicine.The authors describe the predictive utility of the D-dimer assay among patients with the coronavirus disease 2019 syndrome for unprovoked lower extremity deep venous thrombosis.

Coronavirus, COVID-19, Diagnosis and Testing

Molecular Diagnosis of Coronavirus Disease 2019

From Critical Care Explorations. In this article, the authors review current approaches to the molecular diagnosis of coronavirus disease 2019.

Coronavirus, COVID-19, Diagnosis and Testing

Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers

From Critical Care Explorations. The authors conducted a study to determine whether noninvasive urine biomarkers can predict the clinical severity of coronavirus disease 2019.

Coronavirus, COVID-19, Diagnosis and Testing

What do you think the role of antibody testing is? How do you use it at your institution? Do you use it routinely for discharge? Is it used only for certain patients?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on July 8th, 2020.

coronavirus, COVID-19, Diagnosis and Testing

Review of Viral Testing (Polymerase Chain Reaction) and Antibody/Serology Testing for Severe Acute Respiratory Syndrome-Coronavirus-2 for the Intensivist

From Critical Care Explorations. As the SARS-CoV-2 pandemic develops, assays to detect the virus and infection caused by it are needed for diagnosis and management. In this article, the authors describe to clinicians how each assay is performed, what each assay detects, and the benefits and limitations of each assay.

ARDS, Coronavirus, COVID-19, Diagnosis and Testing

Letter to the Editor: Corticosteroid Administration Is Associated With Improved Outcome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2-Related Acute Respiratory Distress Syndrome

From Criticial Care Explorations. The authors report on the use of corticosteroids in mechanically ventilated patients with SARSCoV-2 related acute respiratory distress syndrome.

ARDS, Coronavirus, COVID-19, Diagnosis and Testing, Therapies

Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients

From Critical Care Explorations The authors profiled plasma inflammatory analytes to help understand the host response to COVID19.

Coronavirus, COVID-19, Diagnosis and Testing

Altered Mental Status: Non-ICU Emergency Cards

This resource details how to assess the altered mental status of COVID-19 patients. This is SCCM curated COVID-19 microlearning content.

Clinical presentations, Coronavirus, COVID-19, Diagnosis and Testing

Does any laboratory marker correlate well with or predict severity of illness for COVID-19 patients?

In this question and answer webcast, attendees had the opportunity to post questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were also addressed. Webcast held on June 19, 2020

Coronavirus, COVID-19, Diagnosis and Testing

What is your laboratory’s turnaround time for measuring interleukin-6? What is the average time frame within which ICU patients typically develop cytokine storm?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on June 10th, 2020.

Coronavirus, COVID-19, Diagnosis and Testing, Therapies

Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019

Cytokine release syndrome (CRS) mediated by IL-6 is a critical driver of COVID-19 mortality. The authors review and discuss key immunologic effects of direct IL-6 blockade, downstream non-selective JAK inhibition, and selective JAK2 suppression to treat COVID-19-related CRS.

Comorbidities, Coronavirus, COVID-19, Diagnosis and Testing

Which COVID-19 diagnostic test provides the best results?

In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were also answered. Recorded on: Friday, May 22, 2020

Coronavirus, COVID-19, Diagnosis and Testing, Indications for Laboratory Testing

Have you considered lymphopenia as a criterion to suspect COVID-19?

In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were also answered. Recorded on: Friday, May 22, 2020

Coronavirus, COVID-19, Diagnosis and Testing

Is there any research on the prevalence of vitamin D deficiencies in COVID-19 patients?

In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were also answered. Recorded on: Friday, May 22, 2020

Coronavirus, COVID-19, Diagnosis and Testing

What strategies do you use for presenting patients who are asymptomatic?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on May 27th, 2020.

Coronavirus, COVID-19, Diagnosis and Testing, Indications for Laboratory Testing

What are some typical presentations of patients with early manifestations of COVID-19? Are there any red flags?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on May 27th, 2020.

Coronavirus, COVID-19, Diagnosis and Testing, Indications for Laboratory Testing

On initial assessment, how do you decide whether a patient should be admitted to the ward or to the ICU?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on May 27th, 2020.

Coronavirus, COVID-19, Diagnosis and Testing, Indications for Laboratory Testing

Hypotension: Non-ICU Emergency Cards

This resource details how manage hypotension. This is SCCM curated COVID-19 microlearning content.

Cardiovascular, Coronavirus, COVID-19, Diagnosis and Testing

Letter to the Editor: The Importance of Universal Preprocedural Testing for the Novel Coronavirus 2019

From Critical Care Explorations. In this letter to the editor, the authors recommend universal preprocedural testing and other interventions to safeguard healthcare personnel and patients.

Coronavirus, COVID-19, Diagnosis and Testing, Infection Control

SCCM Pod-415 NIH COVID-19 Treatment Guidelines

The National Institutes of Health has released Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.

Coronavirus, COVID-19, Diagnosis and Testing, Disaster Preparedness

SCCM Pod-412 COVID-19 in Critically Ill Children

Gain valuable insight on the clinical management of COVID-19 and its relevance to the pediatric critical care provider (Ong J, et al. Pediatr Crit Care Med. 2020 Apr 7; Epub ahead of print) with host Elizabeth H. Mack, MD, MS, FCCM, and Jacqueline Ong, MB BChir, MMed (Paeds), MRCPCH.

Coronavirus, COVID-19, Diagnosis and Testing, Disaster Preparedness, Pediatrics

What are your thoughts on COVID-19 transmission and testing?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on April 15, 2020.

Coronavirus, COVID-19, Diagnosis and Testing, Infection Control, Risk of Transmission

SCCM Pod-410 COVID-19 Neurologic Manifestations

Review neurologic manifestations of COVID-19 and other severe respiratory viral contagions (Robinson C, et al. Crit Care Explor. 2020;2:e0107).

Clinical presentations, Coronavirus, COVID-19, Diagnosis and Testing

Pediatric concerns: Symptoms, diagnosis and mortality

This presentation is an overview of symptoms, diagnosis and mortality concerns seen when treating pediatric patients with COVID-19. This is SCCM curated COVID-19 microlearning content.

Coronavirus, COVID-19, Diagnosis and Testing, Statistics, Supportive Care, Therapies

Surviving Sepsis Campaign COVID-19 Guidelines: Infection Control & Testing Recommendations Chart

COVID-19 - - Quick Reference Chart. This chart is to be used as a rapid resource regarding infection control and testing when treating COVID-19 patients.

Coronavirus, COVID-19, Diagnosis and Testing, Infection Control

What is the role of antibody testing, and what is the PCR turnaround time, and the sensitivity and specificity?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered.

Coronavirus, COVID-19, Diagnosis and Testing